2D: Ophthalmic Biomaterials SIG

Date: Wednesday, March 25, 2026
Time: 3:45 PM to 5:15 PM
Room: Hanover AB
Session Type: Concurrent Session 2

Description

The Ophthalmic Biomaterials Special Interest Group focuses on both the development and biocompatibility testing of materials for the augmentation and replacement of diseased ocular tissues and the development and testing of drug delivery systems to the anterior and posterior segments of the eye. Some specific areas of interest include but are not limited to: wetting of surfaces; surface modification and protein adsorption of polymers used for refractive devices; transport through polymers, drug delivery systems, and technologies; vitreous replacement fluids; retinal tamponades, and glaucoma drainage devices for the regulation of intraocular pressure.

Moderators:

Dr. Aliasger Salem
Associate Vice President for Research
University of Iowa, College of Pharmacy

Muhammad Rizwan
Assistant Professor, Biomedical Engineering
University of Texas Southwestern Medical Center

Dr. Jessica Gluck
Assistant Professor
North Carolina State University

  • 3:45 PM. 72. Murine Evaluation of an Albumin-Derived Complex and Nanoparticle Delivery System for Early AMD Treatment.Katelyn Swindle-Reilly, PhD1, Amna Abdalbaqi, MS1, Nagaraj Kerur, DVM, PhD1, Matthew Ohr, MD1, Andre Palmer, PhD1 1The Ohio State University

  • 4:00 PM. 73. Improving Glaucoma Surgery Outcome via Lymphangiogenic Growth Factor Delivery through Antioxidative Hydrogel.Zixi Chen, Bachelor of Science1 1Northwestern University

  • 4:15 PM. 74. Zwitterionic Tissue Expanders Reduce Infection and Fibrosis for Enhanced Biocompatibility.Stephanie Fung, PhD1, Matthew Aronson, PhD2, William Katowitz, MD1, Riccardo Gottardi, PhD2, James Katowitz, MD1 1Children's Hospital of Philadelphia, 2University of Pennsylvania

  • 4:30 PM. 75. Microfluidic Engineering of Ubiquinol-Loaded PLGA Nanoparticles for Ocular Delivery in FECD.Swathi Kalidindi, SK1, jessica skeie, JS1, pornpoj phruttiwanichakun, JP1, Mohammad Alnatour, PhD1, Divya Bande, DB1, mark greiner, MG1, Aliasger Salem, PhD1 1University of Iowa

  • 4:45 PM. 76. Biostable Upconverting Perovskite Quantum Dots for Enhanced Retinal Photosensitivity.Nitisha Mehrotra1, Yifan Zhu, Ph.D1, Ajayan Pulickel, PhD1, Crystal Shin, Ph.D2, Jun Lou, Ph.D1, Ghanshyam Acharya, Ph.D2 1Rice University, 2Baylor College of Medicine

  • 5:00 PM. 77. Injectable Hydrogels for Long-Term IOP Reduction by Suprachoroidal Space Expansion.Daniel Ng1, Yooree Chung, PhD2, Zachary Thomas1, Shinyoung Park1, C. Ethier, PhD3, Mark Prausnitz, PhD1 1Georgia Institute of Technology, 2Emory University, 3Emory University School of Medicine